Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DVU2H8
|
|||
| Drug Name |
CV8102
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Squamous cell carcinoma [ICD-11: 2B60-2D01; ICD-10: C44; ICD-9: 199] | Phase 1 | [1] | ||
| Company |
CureVac
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03291002) Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of CureVac. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.